Dawa Life Sciences
Location
Dawa Life Sciences Pharmaceuticals: Dawa Limited, Baba Dogo Road, Ruaraka, P.O Box 16633-00620 - Nairobi, Kenya
Dawa Life Sciences Animal Health: Medisel Kenya Limited, General Kago Road, P.O Box 540-01000 - Thika, Kenya
History
1994 – Medisel Kenya Limited established in 1995 by Dr. Raju Mohindra and Dr Ajay Patel, focusing on distributing imported pharmaceuticals.
2004 – Acquisition of Dawa Pharmaceuticals Limited, adding pharmaceutical manufacturing capabilities
2013 – Construction of dedicated Beta Lactam manufacturing facility
2016 – Construction of Animal Health manufacturing facility
2020 – Dawa 2.0 Upgrade and expansion of existing general formulation block
2021 – Unification of identity to Dawa Life Sciences .
The pharmaceutical business division manufactures and distributes nearly 200 generic medicines in the region. The major dosage forms of products are tablets, capsules, syrups & suspensions.
Pharmaceuticals
Dawa Limited, established as Dawa Pharmaceuticals Ltd. in 1974, was at the forefront of pharmaceutical manufacturing in East and Central Africa and made products under contract for the UK’s Beecham Pharmaceuticals which is now known as GSK. It was bought by Medisel Kenya Limited in 2004 as a strategy to grow and enhance the pharmaceutical industry in Kenya and then renamed Dawa Limited.
It has since grown and acquired a significant presence across African continent with commercial operations in more than eight countries in the sub-Saharan Africa. It is now one of the largest pharmaceutical manufacturers in the region and offers a wide range of pharmaceutical products. It had less than 50 personnel in October 2004 and has steadily grown to a staff of mire than 450 employees in 2021.
The pharmaceutical division's mission is to enable universal healthcare in the markets they operate in by ensuring access to affordable, high-quality pharmaceuticals. The division focuses on providing generics in the therapeutic areas of infectious diseases, cardiology, neurology, gastroenterology, and endocrinology. The fully integrated supply chain manages the network of manufacturing and delivery geared towards offering a supply of affordable, high-quality pharmaceuticals across Africa. Each year, Dawa Life Sciences Pharmaceuticals Division provides over 100 million treatments across 25 markets on the African continent.
Animal health
Animals continue to form an essential part of the society. Dawa Life Sciences Animal Health division concentrates on marketing products focused on livestock and companion animals. The dedicated facility can produce liquids, sachets, boluses, premixes, and external preparations for Animal Health.
Operations
Dawa Life Sciences is a leading manufacturer and marketer in Kenya. It is expanding its scope of operation to become a global manufacturer while meeting various market demands. It has already an established a high-end manufacturing facility for penicillin products. It is planning to establish another new facility by investing US$290 mn to cater the need of growing business demands. It has business operations in Kenya, Uganda, Rwanda, Burundi, Zambia, Malawi, Ivory Coast, Democratic Republic of the Congo and South Sudan.
Ownership
The shares of stock of Dawa Life Sciences Pharmaceuticals and Animal Health Divisions are privately owned; belonging to Dawa Life Sciences.
Dawa Life Sciences
Dawa Life Sciences is a conglomerate of three separate entities, all of which are aligned towards achieving the Group’s overall strategy. The companies and their lines of business are as below:
Dawa Limited: It is a well-known pharmaceutical manufacturer & marketer in Africa (the anchor company).
Medisel (K) Limited: It is the parent and flagship company of the Dawa Life Sciences, a leading importer and marketer of pharmaceutical (for both human & animal health) & surgical products.
Forest Road Development Limited: It is a premium real estate company dedicated to the development of high-level properties in varied segments including residential and commercial.
See also
References
- ^ Kariuki, James (24 September 2017). "Drugs firm to spend Sh3 billion on Nairobi plant expansion". Business Daily Africa. Nairobi. Retrieved 24 September 2017.
- ^ NBM (10 November 2015). "Dawa Limited acquires KEL Chemicals". Nairobi: Nairobi Business Monthly (NBM). Retrieved 26 September 2017.
- ^ "Our Team". Dawa Life Sciences. Retrieved 2021-07-28.
- ^ "Home". Dawa Life Sciences. Retrieved 2021-07-28.
- ^ "Dawa Group | Dawa Limited | Pharmaceutical Manufacturer | Kenya". Dawa Limited. Retrieved 2020-05-29.
- ^ Introducing Dawa Life Sciences, retrieved 2021-07-28
- ^ TABJ (2004). "Dawa Limited". The African Business Journal. Retrieved 25 September 2017.
- ^ African Hidden Champions: Dawa Group, retrieved 2021-07-28
- ^ "Discover". Dawa Life Sciences. Retrieved 2021-07-28.
- ^ "East Africa: Dawa Group's journey from a trading business to a leading pharmaceutical manufacturer". How We Made It In Africa. 2021-03-09. Retrieved 2021-07-28.
- ^ Kwach, Julie. "Pharmaceutical Companies in Kenya Directory". Tuko.co.ke - Kenya news. Retrieved 2018-04-11.
- ^ "Dawa Ltd. announces Nairobi pharmaceutical plant expansion". www.healthcareglobal.com. Retrieved 2018-04-11.
- ^ DG (26 September 2017). "Dawa Group Profile". Thika: Dawa Group (DG). Retrieved 26 September 2017.